In addition, forced overexpression of PIMs in AML cells decreases sensitivity of AML blasts to targeted FLT3-ITD inhibition by a mechanism that likely involves a direct phosphorylation of FLT3 by PIMs, reducing affinity of the FLT3-ITD receptor to its inhibitors [22, 50]. The gene discussed is FLT3; the disease is acute myeloid leukemia.